The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.

Initially isolated as the dominant suppressor of the mutant epidermal growth factor receptor (ellipse), the Dachshund gene plays a key role in metazoan development regulating the Retinal Determination Gene Network. Herein, the DACH1 gene was expressed in normal prostate epithelial cells with reduced expression in human prostate cancer. DACH1 inhibited prostate cancer cellular DNA synthesis, growth in colony forming assays, and blocked contact-independent growth in soft agar assays. DACH1 inhibited androgen receptor (AR) activity, requiring a conserved DS Domain (Dachshund domain conserved with Ski/Sno) that bound NCoR/HDAC and was recruited to an androgen-responsive gene promoter. DACH1 inhibited ligand-dependent activity of AR mutations identified in patients with androgen-insensitive prostate cancer. The DS domain was sufficient for repression of the AR wild-type but failed to repress an AR acetylation site point mutant. These studies show a role for the Retinal Determination Gene Network in regulating cellular growth and signaling in prostate cancer.

[1]  Chenguang Wang,et al.  Sirtuins, nuclear hormone receptor acetylation and transcriptional regulation , 2007, Trends in Endocrinology & Metabolism.

[2]  Mahadev Rao,et al.  Cyclin D1 Inhibits Peroxisome Proliferator-activated Receptor γ-mediated Adipogenesis through Histone Deacetylase Recruitment* , 2005, Journal of Biological Chemistry.

[3]  V. Ogryzko,et al.  p300 and p300/cAMP-response Element-binding Protein-associated Factor Acetylate the Androgen Receptor at Sites Governing Hormone-dependent Transactivation* , 2000, The Journal of Biological Chemistry.

[4]  B. O’Malley,et al.  Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.

[5]  Chawnshang Chang,et al.  Androgen receptor corepressors: An overview , 2005, The Prostate.

[6]  Itaru Matsumura,et al.  Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine‐dependent growth of hematopoietic cells , 1999, The EMBO journal.

[7]  Ales Cvekl,et al.  DACH1 Is a Cell Fate Determination Factor That Inhibits Cyclin D1 and Breast Tumor Growth , 2006, Molecular and Cellular Biology.

[8]  T. Tong,et al.  Cancer statistics, 1994 , 1994, CA: a cancer journal for clinicians.

[9]  L. Sánchez,et al.  Sex determination genes control the development of the Drosophila genital disc, modulating the response to Hedgehog, Wingless and Decapentaplegic signals. , 2001, Development.

[10]  W. Farrar,et al.  Androgen Receptor as a Therapeutic Target for Androgen Independent Prostate Cancer , 2006, American journal of therapeutics.

[11]  R. Pestell,et al.  Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells , 2006, Oncogene.

[12]  Anping Li,et al.  DACH1 Inhibits Transforming Growth Factor-β Signaling through Binding Smad4* , 2003, Journal of Biological Chemistry.

[13]  B. Groner,et al.  Induction of 3 b-Hydroxysteroid Dehydrogenase / D 5D 4 Isomerase Type 1 Gene Transcription in Human Breast Cancer Cell Lines and in Normal Mammary Epithelial Cells by Interleukin-4 and Interleukin-13 , 1998 .

[14]  R. Vessella,et al.  Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.

[15]  N. Pattabiraman,et al.  Hormonal Control of Androgen Receptor Function through SIRT1 , 2006, Molecular and Cellular Biology.

[16]  S. Fuqua,et al.  Androgen Receptor Acetylation Governs trans Activation and MEKK1-Induced Apoptosis without Affecting In Vitro Sumoylation and trans-Repression Function , 2002, Molecular and Cellular Biology.

[17]  S. Akira,et al.  Macrophage/Cancer Cell Interactions Mediate Hormone Resistance by a Nuclear Receptor Derepression Pathway , 2006, Cell.

[18]  Chenguang Wang,et al.  Acetylation in nuclear receptor signaling and the role of sirtuins. , 2008, Molecular endocrinology.

[19]  J. Bourhis,et al.  Environmental, genetic, and molecular features of prostate cancer. , 2004, The Lancet. Oncology.

[20]  Chenguang Wang,et al.  Nuclear receptor modifications and endocrine cell proliferation , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  E. Rosen,et al.  Acetylation of Androgen Receptor Enhances Coactivator Binding and Promotes Prostate Cancer Cell Growth , 2003, Molecular and Cellular Biology.

[22]  J. C. Ghosh,et al.  Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT* , 2003, The Journal of Biological Chemistry.

[23]  S. Balk,et al.  The Androgen Receptor Recruits Nuclear Receptor CoRepressor (N-CoR) in the Presence of Mifepristone via Its N and C Termini Revealing a Novel Molecular Mechanism for Androgen Receptor Antagonists* , 2005, Journal of Biological Chemistry.

[24]  Y. Shang,et al.  Formation of the androgen receptor transcription complex. , 2002, Molecular cell.

[25]  G. Rubin,et al.  dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila. , 1994, Development.

[26]  Y. Yarden,et al.  Cyclin D1 Is Required for Transformation by Activated Neu and Is Induced through an E2F-Dependent Signaling Pathway , 2000, Molecular and Cellular Biology.

[27]  D. Kazmin,et al.  Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion. , 2003, Cancer research.

[28]  L. Forman,et al.  Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. , 2007, Molecular endocrinology.

[29]  Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor. , 2002, Molecular endocrinology.

[30]  O. Jänne,et al.  Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. , 2004, Molecular endocrinology.

[31]  Xue Li,et al.  Tissue-Specific Regulation of Retinal and Pituitary Precursor Cell Proliferation , 2002, Science.

[32]  Anping Li,et al.  Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8 , 2008, Proceedings of the National Academy of Sciences.

[33]  R. Evans,et al.  A transcriptional co-repressor that interacts with nuclear hormone receptors , 1995, Nature.

[34]  G. Buchanan,et al.  Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  G. Coetzee,et al.  GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor , 2005, Biological chemistry.

[36]  B. Katzenellenbogen,et al.  Direct Acetylation of the Estrogen Receptor α Hinge Region by p300 Regulates Transactivation and Hormone Sensitivity* , 2001, The Journal of Biological Chemistry.

[37]  O. Jänne,et al.  Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. , 2001, Molecular endocrinology.

[38]  B. S. Baker,et al.  The Drosophila sex determination hierarchy modulates wingless and decapentaplegic signaling to deploy dachshund sex-specifically in the genital imaginal disc. , 2001, Development.

[39]  G. Bubley,et al.  Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. , 1995, The New England journal of medicine.

[40]  C. Heinlein,et al.  Androgen receptor in prostate cancer. , 2004, Endocrine reviews.

[41]  Anping Li,et al.  Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth. , 2007, Molecular biology of the cell.

[42]  A. Joachimiak,et al.  Structure of the retinal determination protein Dachshund reveals a DNA binding motif. , 2002, Structure.